Practice Management

Latest News


Medical Economics Insider: Save your practice

Check out our inaugural edition of our interactive publication, featuring in-depth reporting, expert insights, exclusive data, and more!

Medical Economics Insider: Save your practice


The vast majority of doctors own and enjoy Apple iPads, but few use them at their practice, according to survey results released by a market research firm.

Disappointed, but not surprised was the reaction of the American Academy of Family Physicians president after Congress passed legislation last week which saved Medicare payments from a drastic cut, but didn’t solve the underlying problem.

Nearly half of physician practices use electronic health record systems, but primary care physicians are not among the top or bottom users, according to survey results by a market research firm.

More osteopathic medical students are headed to family medicine post-graduate training than any other specialty, according to the American Osteopathic Association.

Virginia physicians are sharing messages, patient records, lab results, dictated reports, discharge summaries, and other scanned documents with a secured statewide messaging service that launched this month.

Medical Economics provides a place to share experience and advice, which is why the Doctors' Writing Contest issue is a great time to announce a new editor-in-chief and Medical Economics' honor as Medical Marketing & Media's 2012 Brand of the Year.

Questions include MRI accreditation, multi-procedures, and signature requirements. Find out the answers to your pressing coding questions.

More people in Massachusetts have health insurance now than when mandated coverage was enacted. Despite the gains, costs are still climbing. Learn the national implications.

National insurer WellPoint announced a medical home program that could raise your compensation by 50%. Eligibility won’t be easy and could affect your whole practice.

A recent study shows doctors are creatures of habit when prescribing medications depending on the category. One drug class, however, doesn’t seem to have a clear top choice.